Antibacterial activity against imipenem-sensitive Pseudomonas aeruginosa isolate 1091-05 infected in sc dosed neutropenic-C3H/HeN mouse assessed as mouse survival administered 4 hrs post infection followed by BID dosing for two days measured on day 10